questionText: To ask the Secretary of State for Health and Social Care, whether NHS England or NHSBSA have identified any gaps or inconsistencies in national prescribing or outcomes data relating to puberty blockers in under-18s.
answerText: In March 2024, NHS England published a suite of documentation relating to its decision to remove gonadotrophin releasing hormone analogues as a routine treatment option in the National Health Service for children under 18 years old with gender dysphoria. ...
heading: Puberty Suppressing Hormones: Children